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Nitric oxideYeast metacaspase (Yca1p) is required for the execution of apoptosis upon a wide range of stimuli. However,
the speciﬁc degradome of this yeast protease has not been unraveled so far. By combining different method-
ologies described as requisites for a protein to be considered a protease substrate, such as digestome analysis,
cleavage of recombinant GAPDH by metacaspase and evaluation of protein levels in vivo, we show that upon
H2O2-induced apoptosis, the metabolic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a
speciﬁc target of metacaspase. Nitric oxide (NO) signaling, which mediates H2O2-induced apoptosis, is re-
quired for metacaspase speciﬁc GAPDH cleavage. In conclusion, in this work we identiﬁed GAPDH as the
ﬁrst direct yeast metacaspase substrate described so far. Although mammalian caspases and yeast metacas-
pase apparently have distinct target cleavage sites, GAPDH arises as a common substrate for these proteases.dehyde-3-phosphate dehydro-
methyl ester
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Over a decade ago, a family of proteases presenting structural sim-
ilarities to caspases was identiﬁed in protists, fungi and plants [1].
These proteases were named metacaspases and classiﬁed, according
to the presence or absence of a N-terminal prodomain containing a
proline-rich repeat motif, as type I or type II, respectively. In spite of
the structural similarity with the remotely related caspases, a large
body of accumulating evidence shows that all metacaspases are high-
ly speciﬁc for P1-Arg and P1-Lys substrates (reviewed in [2]).
Yeast cells have a single gene, YCA1, encoding a type I metacaspase
that was ﬁrst implicated in the execution of oxidative stress induced
cell death [3] but that is estimated to participate in approximately
40% of the described yeast apoptotic scenarios [4]. Nevertheless,
non-death functions have also been assigned to yeast metacaspase
such as cell cycle regulation [5] and protein catabolism [6]. Although
the mechanisms regulating this multifunctional protein, metacaspase,still remain elusive, it is known that metacaspase activity is regulated
through S-nitrosation and thus dependent on the endogenous levels
of nitric oxide (NO) [7]. S-nitrosation of one metacaspase Cys residue
keeps it inactive. However, a second catalytic Cys residue, highly con-
served in all known metacaspases but absent in all members of cas-
pases, can rescue metacaspase activity in the presence of high NO
levels [7]. Accordingly, in yeast H2O2-induced apoptotic condi-
tions [3,8], a cell death process dependent on metacaspase activity
and NO generation, metacaspase activity and cell death are abolished
in the presence of L-NAME, an inhibitor of NO synthesis [9,10].
One of the major mechanistic challenges for understanding the
role of metacaspases in cell survival and death is still the identiﬁca-
tion of their natural substrates. At the present the only protein
found to be cleaved by metacaspases in vivo is the evolutionarily con-
served TSN (Tudor staphylococcal nuclease) [11] found in all eukary-
otes except in budding yeast [11]. Thus, although in yeast,
metacaspase is essential for apoptosis execution upon a wide range
of either physiological or external stimuli [3,12], the substrates tar-
geted by this protease are still unknown.
In this context, the identiﬁcation of yeast metacaspase speciﬁc
degradome is crucial for unraveling the signaling pathways regulated
by yeast metacaspase and to clarify its function in cell death. Using a
digestome analysis, together with in vitro and in vivo protein proces-
sing assays, we found evidence indicating that the yeast metabolic
enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a
speciﬁc substrate of yeast metacaspase.
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2.1. Yeast strains and plasmids
Saccharomyces cerevisiae BY4742 (MATα his3Δ1 leu2Δ0 lys2Δ0
ura3Δ0) strain and its isogenic derivative Δyca1 (EUROSCARF, Frankfurt,
Germany) were used. For construction of the metacaspase-
overexpressing strain, YCA1 was ampliﬁed by PCR (primers 5′-
ccgggaattcgatgtatccaggtagtggacgt-3′ and 5′-ccggggatccctacataat
aaattgcagatttacgtc-3′), using genomic DNA, isolated from
BY4742 strain and cloned into the EcoRI and BamHI sites of
pGREG546 (EUROSCARF, Frankfurt, Germany), which displays
GST at N-terminal and a galactose-inducible promoter, generating
pGREG546YCA1. Strain Δyca1 was transformed with pGRE-
G546YCA1, generating strain YCA1overexp.
2.2. Metacaspase overexpression and activation
YCA1overexp cells were grown until exponential growth phase
(OD640nm=0.5) on synthetic complete (SC) medium containing glu-
cose (2%, w/v), yeast nitrogen base (0.17%, w/v, Difco), 300 mg/l of
L-leucine, 50 mg/l of L-histidine and 50 mg/l of L-lysine. Cells were
washed, ressuspended in SC medium containing galactose (2%, w/v)
and incubated at 26 °C with stirring (150 r.p.m.) to induce metacas-
pase overexpression. After 16 h, 107 cells/ml were harvested and
resuspended in fresh SC medium with galactose (2%, w/v), and meta-
caspase was activated by the addition of 2 mM of H2O2 [3] and incu-
bation for 200 min at 26 °C with stirring (150 r.p.m.).
2.3. Inhibition of NO production
Inhibition of NOproductionwas achieved by pre-incubation of yeast
cells for 1 h with the non-metabolized L-arginine analog, Nω-nitro-L-
arginine methyl ester (L-NAME; Sigma-Aldrich), as described [8,9].
2.4. Protein extracts
Total protein extracts were prepared from untreated and H2O2-
treated yeast cells as described [9]. Protein concentration was deter-
mined by Bradford method [13].
2.5. Digestome analysis
Digestome analysis was performed according to the methodology
previously described in [14], with adaptations. Four hundred micro-
grams of total protein extracts obtained from untreated wild-type
yeast cells were resolved by SDS-PAGE 12% (ﬁrst dimension). After mi-
gration, the lanes were excised and treated as described in [14], soaked
in digestion buffer [50 mM Tris-HCl, 150 mM NaCl and 10 mM DTT]
with 5 mg of either active metacaspase-enriched extracts (obtained
from H2O2-treated YCA1overexp cells) or inactive metacaspase-enriched
extracts (obtained from H2O2-treated Δyca1 or untreated YCA1overexp
cells), incubated overnight at 37 °C, washed with ultrapure water and
incubated in loading buffer [50 mM Tris (pH 6.8), 2% SDS, 0.1% bromo-
phenol blue, 10% glycerol, 2.5% β-mercaptoethanol] for 10 min at
95 °C. After cooling, lanes were subjected to a second dimension SDS-
PAGE. Proteins in the gels were immunoblotted as described below or
stained using Colloidal Blue Staining Kit (Invitrogen) and the spots lo-
cated below the diagonal, corresponding to cleaved proteins, were ex-
cised from the gels and identiﬁed by MALDI-TOF mass spectrometry
as described in [13].
2.6. Assessment of intracellular reactive oxygen species (ROS)
Free intracellular ROS were detected with dihydrorhodamine 123
(DHR123) (Molecular Probes, Eugene, OR, USA). DHR123 was addedfrom a 1 mg/ml stock solution in ethanol, to 5×106 cells/ml sus-
pended in PBS, reaching a ﬁnal concentration of 15 μg/ml. Cells were
incubated for 90 min at 30 °C in the dark, washed in PBS and analyzed
by ﬂow cytometry. Flow cytometric assays were performed on a BD
LSR II™ (Becton Dickinson, NJ, USA) using BD FACSDiva Software 6.0
(Becton Dickinson, NJ, USA). Twenty thousand cells per sample were
analyzed using the FlowJo software (Tree Star, Ashland, OR, USA).
2.7. TUNEL assay
DNA strand breaks were assessed by a TUNEL assay with the In
situ Cell Death Detection Kit, POD (Roche Applied Science, Indianapo-
lis, IN). Yeast cells were initially ﬁxed with 3.7% formaldehyde fol-
lowed by digestion of the cell walls with lyticase. After preparation
of cytospins, the slides were rinsed with PBS, incubated in permeabi-
lization solution (0.1%, v/v, Triton X-100 and 0.1%, w/v, sodium cit-
rate) for 3 min on ice, rinsed twice with PBS, and incubated with
10 μL of TUNEL reaction mixture (terminal deoxynucleotidyl transfer-
ase and FITC-dUTP) for 60 min at 37 °C . Finally, the slides were rinsed
three times with PBS and a coverslip was mounted with a drop of
anti-fading agent Vectashield (Molecular Probes, Eugene, OR) and
with 2 μL of 50 μg/mL propidium iodide (PI, Molecular Probes) solu-
tion in Tris buffer (10 mM, pH 7.0) with MgCl2 (5 mM) and RNase
(0.5 μg/mL). Cells were visualized with an Olympus PlanApo 60X/oil
objective, with a numerical aperture of 1.42. For quantiﬁcation of
the number TUNEL-positive cells, at least 400 cells from three inde-
pendent assays were counted. Data express the percentage of
TUNEL-positive cells compared to the total number of counted cells.
2.8. Recombinant protein expression and cleavage assay
For production of recombinant GAPDH, yeast GAPDH (TDH3) was
ampliﬁed by PCR (primers 5′-ggggacaagtttgtacaaaaaagcaggctccatggt-
tagagttgctatt-3′ and 5′-ggggaccactttgtacaagaaagctgggtcttaagccttgg-
caacgtg-3′) from wild-type genomic DNA. PCR product was then
inserted into pDEST17 vector (Invitrogen) using the gateway® tech-
nology (Invitrogen), generating the plasmid pDEST17GAPDH. E. coli
strain BL21 pLys was transformed with vectors pDEST17GAPDH or
pET23aYCA1 (kindly provided by Dr. E. Lam).
Recombinant GAPDH and metacaspase expression was induced
with 1 or 0.4 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG), re-
spectively, at 37 °C (GAPDH) or 28 °C (metacaspase). GAPDH was
obtained as inclusion bodies that were solubilised in 50 mM Tris–
HCl, 0.2 M NaCl, 2 mM EDTA, pH 8.0. Refolding conditions were
screened using the iFOLD Protein Refolding System 2 (Novagen).
The protein was refolded by dilution in 50 volumes of refolding buffer
[50 mM TAPS, pH 8.5, 1.5 M Sorbitol, 24 mM NaCl, 1 mM KCl, 1 mM
TCEP] overnight at 22 °C with mild agitation. Bacterial cells expres-
sing YCA1 were broken by sonication as described in [15], and the
resulting supernatants used as described hereafter.
Metacaspase cleavage of GAPDH was assayed by incubating 500 μl
of recombinant GAPDH in refolding buffer with 20 μl of bacterial ex-
tracts obtained upon expression of metacaspase and 520 μl of 2×
buffer A [0.2% (w/v) CHAPS, 0.2 M HEPES, 20% (w/v) Sucrose,
20 mM TCEP, pH 7.5]. As a negative control, GAPDH was incubated
with bacterial extracts obtained from E. coli cells expressing the
empty vector, pET23a, and as a positive control, 500 μl of recombinant
GAPDH in refolding buffer was mixed with 100 μl of sea bass recom-
binant active caspase-1 in refolding buffer and with 600 μl of 2× buff-
er A. Samples were incubated overnight at 22 °C, precipitated with
trichloroacetic acid, resolved by SDS-PAGE and immunoblotted.
2.9. Immunoblotting
Proteins in the gels were transferred to nitrocellulose membranes.
Total protein extracts were probed with monoclonal mouse anti-
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goat anti-actin (kindly provided by Dr. C.W. Gourlay) at a dilution of
1:5000. IgGs on the blots were detected with horseradish peroxidase-
conjugated anti-mouse, anti-rabbit or anti-goat IgG secondary anti-
bodies (Cell Signaling Technology) using an enhanced chemilumines-
cence kit (Pierce). The expression of active metacaspase in E. coli
harboring the pET23aYCA1 plasmid was conﬁrmed using polyclonal
rabbit anti-Yca1p antibody (kindly supplied by Dr. F. Madeo).
2.10. Statistical analysis
The arithmetic means for the free intracellular ROS and TUNEL
staining quantiﬁcation and comparison of cell survival rates are pre-
sented with standard deviation with a 95% conﬁdence value. Statisti-
cal analysis was carried out using independent samples t-test
analysis. A p-value lower than 0.05 was assumed to denote a signiﬁ-
cant difference.
3. Results
3.1. Digestome analysis reveals GAPDH as a cleavage target of metacaspase
To identify speciﬁc targets of yeast metacaspase we performed a
digestome analysis, as previously described [14]. Although digestome
analysis, an in vitro assay, does not mimic cellular physiological con-
ditions, it represents a starting point for searching putative speciﬁc
substrates of proteases. In a ﬁrst dimension SDS-PAGE, total protein
extracts from untreated wild-type yeast cells were resolved. Upon
protein separation, gel lanes were excised and incubated with active
metacaspase-enriched extracts obtained from YCA1overexp cells un-
dergoing apoptosis induced by H2O2 treatment (a condition known
to induce metacaspase activation [3]). After incubation, gel lanes
were mounted on a second SDS-PAGE gel and proteins resolved a sec-
ond time by molecular weight. Digestome analysis of total protein ex-
tracts revealed numerous spots below the diagonal, corresponding to
protein fragments that originated from cleavage during the incuba-
tion of the gel lane with active metacaspase-enriched extracts
(Fig. 1A). Three spots (Fig. 1A, spot 1, 2 and 3) were analyzed by
mass spectrometry and indicate the presence of peptide fragments
of the isoforms 2 or 3 (Tdh2p/Tdh3p), but not of the isoform 1
(Tdh1p), of the glycolytic enzyme glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) (Fig. 1B). Immunoblotting of the digestome anal-
ysis gel with an anti-GAPDH antibody showed three GAPDH
fragments immediately below the diagonal (Fig. 1C1, spots 4, 5 and
6). Some of these labeled fragments are most likely the complemen-
tary GAPDH protein fragments of the peptides identiﬁed by mass
spectrometry (Fig. 1A and B).
The question whether GAPDH cleavage observed was due to meta-
caspase or to other activated proteases was addressed. For such pur-
pose, gel lanes were also incubated either with extracts from
untreated YCA1overexp cells or H2O2-treated Δyca1 cells, two paradig-
matic conditions of absence of metacaspase activity. Digestome anal-
ysis showed that the absence of metacaspase activity (Fig. 1C2 and
C3) resulted in the appearance of a GAPDH fragment (spot 6) below
the full-length GAPDH protein that is also present in the digestome
obtained with H2O2-treated YCA1overexp cells, indicating that this is a
biological phenomenon independent of metacaspase activity. Howev-
er, two other spots (spots 4 and 5) were detected in the digestome
analysis under active metacaspase conditions (Fig. 1C) and were not
generated when active metacaspase was absent. These data suggest
that GAPDH is cleaved by metacaspase and that speciﬁc cleavage
products only occur when metacaspase is active.
The observed in vitro cleavage of GAPDH by active metacaspase-
enriched extracts suggests a relevant role of metacaspase proteolytic
activity in targeting a crucial metabolic enzyme during yeast apopto-
sis. In mammals, the targeting of metabolic enzymes by caspases isnot a newly described phenomenon as evidenced in the caspase sub-
strate database (CASBAH database) [16].
3.2. Recombinant GAPDH is cleaved in vitro by recombinant metacaspase
To further support the speciﬁc cleavage of GAPDH by active meta-
caspase, recombinant metacaspase-enriched bacterial extracts were
added to recombinant GAPDH (isoform 3 - Tdh3p, the main target
of fragmentation during H2O2-induced apoptosis [9]). As shown in
Fig. 2, the addition of a metacaspase-enriched bacterial extract to re-
combinant GAPDH was sufﬁcient to induce its fragmentation, with
the appearance of fragments with molecular weights similar to the
ones detected in the immunoblot of the digestome gel (Fig. 1C1).
When protein extracts from E. coli cells expressing the empty vector
were added to GAPDH, no fragmentation was observed (Fig. 2).
GAPDH has also been reported to be speciﬁcally cleaved by caspase-
1 in higher eukaryotic cells [17]. Since GAPDH sequence is highly con-
served among species, as a positive control, we added recombinant
ﬁsh caspase-1 to recombinant yeast GAPDH. As expected, ﬁsh cas-
pase-1 was able to cleave yeast GAPDH (Fig. 2), although the four
resultingGAPDH fragmentswere distinct from the ones produced by in-
cubation with recombinant yeast metacaspase, showing that these pro-
teases have distinct cleavage target sites. Our results indicate that yeast
metacaspase recognizes target sequences distinct from the ones recog-
nized by caspases of higher eukaryotes corroborating previous results
that attributed to metacaspase an arginine/lysine-speciﬁc endopepti-
dase activity in contrast to the cysteine-aspartic proteases of caspases
[15].
Altogether, these results show that althoughmetacaspases have a pro-
teolytic activity distinct from caspases, their targetedmolecular pathways
upon an apoptotic stimulus display similarities and during apoptotic cell
death both of them degrade metabolic enzymes. Next, we went on to
evaluate if cleavage of GAPDH by metacaspase also occurs during in
vivo induction of yeast apoptosis by H2O2 [3].
3.3. In vivo metacaspase cleavage of GAPDH during H2O2-induced apoptosis
is dependent on NO levels
Several proteins shown to be speciﬁcally cleaved by in vitro meth-
odologies, such as the digestome analysis, proved later not to be sub-
strates of the caspases under in vivo apoptotic conditions. Thus,
metacaspase speciﬁc GAPDH fragmentation was evaluated by immu-
noblot analysis of the GAPDH levels, in total protein extracts from
wild-type and Δyca1 cells challenged with H2O2. As expected, H2O2
(concentrations ranging from 0.5 mM to 2 mM) induced apoptotic
cell death of wild-type cells as revealed by the increasing percentage
of cells displaying TUNEL positive phenotype and high levels of reac-
tive oxygen species (ROS) (Fig. 3). In contrast, Δyca1 cells were more
resistant to H2O2 and thus have increased survival, TUNEL negative
phenotype and lower percentage of cells with high ROS levels
(Fig. 3). Moreover, apoptotic cell death of wild-type cells was accom-
panied by a clear reduction of the GAPDH levels that was not ob-
served in Δyca1 cells (Fig. 3E), suggesting the requirement of
metacaspase for the occurrence of fragmentation of this protein in
vivo. Simultaneously, it was possible to detect a GAPDH fragment
with lower molecular weight (15 kDa) (Fig. 3E) compatible with
one of the fragments observed by digestome analysis (Fig. 1C1). The
absence of other fragments in the immunoblot analysis, as observed
by in vitro digestome assay, suggests that the peptides liberated
from the precursor protein, can be further processed, resulting in
fragments that are released or degraded.
These results suggest that GAPDH is a speciﬁc target of metacas-
pase during H2O2-induced apoptosis, reinforcing the link between
metabolism and cell death.
Our previous data have demonstrated that upon H2O2-induced ap-
optosis, yeast cells are able to synthesize nitric oxide (NO) leading to
Fig. 1. GAPDH is a target of cleavage by metacaspase-enriched protein extracts. (A) Total protein extracts from untreated wild-type cells subjected to SDS-PAGE, incubated with
active metacaspase-enriched extracts (from H2O2-treated YCA1overexp cells) and then subjected to a second SDS-PAGE. The gel was Coomassie blue-stained. Spots below diagonal
(1, 2 and 3), corresponding to cleaved proteins, were excised and analyzed by MALDI-TOF mass spectrometry. (B) Sequence of GAPDH isoforms Tdh1p (NP_012483.1), Tdh2p
(NP_012542) and Tdh3p (NP_011708) retrieved fromNCBI. Mass spectrometry analyses of the three spots identiﬁed peptides matches to Tdh2p and Tdh3p but not Tdh1p. Sequence
parts covered by the detected peptides are indicated with different colors. Pink colored peptide was identiﬁed both in spot 2 and 3. (C) Coomassie-stained diagonal gels of protein
extracts fromwild-type untreated cells incubated with protein extracts from (1) H2O2-treated YCA1overexp cells; (2) untreated YCA1overexp cells and (3) H2O2-treated Δyca1 cells, and
respective immunoblot analysis with a monoclonal anti-GAPDH antibody reveal spots 4, 5 and 6. Data are representative of at least three independent experiments.
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caspase speciﬁc GAPDH cleavage and NO signaling are correlated. To
elucidate if GAPDH metacaspase-dependent fragmentation requires
its previous S-nitrosation, NO synthesis was inhibited, through the
pre-incubation of cells with the L-arginine analog Nω-nitro-L-arginine
methyl ester (L-NAME) [9,10], and the in vivo GAPDH levels assessedFig. 2. In vitro cleavage of recombinant GAPDH by metacaspase-enriched bacterial extracts
andpuriﬁed caspase-1. Immunoblot of recombinantGAPDH incubatedwith 20 μl of protein
extracts from bacteria harboring pET23a empty vector, 20 μl of protein extracts from bac-
teria expressing metacaspase or recombinant puriﬁed caspase-1. Twenty microliters of
protein extracts from bacterial cells expressing metacaspase were loaded as control. Data
are representative of at least three independent experiments.by immunoblot. NO synthesis inhibition resulted in the maintenance
of GAPDH levels, in contrast with the H2O2-treated wild-type cells
without L-NAME pre-incubation (Fig. 3F). These results revealed a
causal relation between metacaspase activity and NO levels, as previ-
ously reported [7,10] indicating that the in vivo occurrence of meta-
caspase speciﬁc GAPDH cleavage upon H2O2-induced apoptosis
requires NO signaling.
4. Discussion
Metacaspase seems to be an executor of the apoptotic events ob-
served in S. cerevisiae (reviewed in [4,12]). Although signiﬁcant ef-
forts have gone into the clariﬁcation of the role of metacaspase in
yeast cell death processes, its role is still enigmatic. The routes to un-
ravel yeast metacaspase functions undoubtedly have to pass through
understanding howmetacaspase recognizes its substrates, the identi-
ﬁcation of its speciﬁc substrates and how substrate cleavage is in-
volved in the apoptotic phenotype. Although it was described that
in vivo metacaspases cleave the evolutionarily conserved TSN
(Tudor staphylococcal nuclease) [11], TSN is absent in budding
yeast [11] and thus the substrates targeted by yeast metacaspase
are still unknown.
Fig. 3. GAPDH speciﬁc cleavage by metacaspase during H2O2-induced apoptosis is dependent on NO levels. (A) Comparison of the survival rate of wild-type and Δyca1 cells upon
H2O2 treatment. (B) Percentage of wild-type and Δyca1 cells exhibiting high levels of intracellular ROS detected by FACS measurements of the dihydrorhodamine 123 ﬂuorescence.
(C) Percentage of wild-type and Δyca1 cells displaying TUNEL positive phenotype. (D) Epiﬂuorescence and bright ﬁeld micrographs of untreated and H2O2-treated wild-type
and Δyca1 cells displaying TUNEL reaction to visualize double-strand DNA breaks. Cells were co-stained with propidium iodide in order to facilitate nuclei visualization.
Bar, 5 μm. (E) Immunoblot analysis of GAPDH and actin protein levels in 40 μg of total protein extracts of H2O2-treated and untreatedwild-type andΔyca1 cells. (F) Immunoblot analysis
of GAPDH levels in 40 μg of total protein extracts of untreated and H2O2-treated wild-type yeast cells after pre-incubation with the L-arginine analog, L-NAME. Statistical signiﬁcance
(*Pb0.05) was determined by Student's t-test.
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tein to be considered a caspase substrate [18] allows us to assignGAPDH
as a metacaspase speciﬁc substrate. GAPDH cleavage was observed in
vitro by digestome analysis complemented with mass spectrometry
and immunoblot and validated by its speciﬁc cleavage after incubation
of recombinant GAPDH with recombinant metacaspase. Moreover, the
occurrence of GAPDH metacaspase-dependent cleavage was further
conﬁrmed by an in vivo assay in cells undergoing apoptosis with
GAPDH displaying reduced levels. Moreover, the physiological rele-
vance of GAPDH fragmentation is also supported by previous results
showing that GAPDH is a target of extensive fragmentation upon
H2O2-induced apoptosis [9,19]. It is important to acknowledge that,
proteolytic cleavage of GAPDH, as that of any protein, can result in a
gain- or loss-of-function for the protein. It is well known that H2O2
treatment (1.5 mM) of S. cerevisiae cells results in the decrease of
GAPDH activity associated with a drop of the ATP levels [20]. The re-
duced ATP levels affect cellular homeostasis and can decrease the efﬁ-
ciency of energy-dependent processes and ATP-mediated cell signal
transduction such as actin dynamics [21] increasing the sensitivity to
apoptotic insult. Nevertheless, the hypothesis that GAPDH cleavage re-
sults in a gain-of-function is also acceptable in the light of our previous
results [9] showing an increased survival of TDH2- and TDH3-disrupted
cells exposed to H2O2-induced apoptosis. The GAPDH pleiotropicfunctions, linked to the various intracellular localizations of the enzyme,
as well as the observation that GAPDH overexpressing cells behave as
wild-type cells when challenged with H2O2 (data not shown) further
complicates the elucidation of this aspect. Nonetheless, the accumulat-
ing evidence indicates that yeast GAPDH cleavage bymetacaspase could
contribute to H2O2-induced apoptosis independently of whether or not
this proteolysis results in a gain- or loss-of-function. We and others
have shown that GAPDH is S-nitrosated by the NO generated upon
H2O2-induced apoptosis [9], and that inhibition of NO synthesis in
yeast cell leads to a dramatic reduction of metacaspase activity [10].
Hereinwe show that NO production is needed for themetacaspase spe-
ciﬁc cleavage of GAPDH upon H2O2-induced apoptosis, similar to what
occurs in higher eukaryotic cells, in which NO has already been ascer-
tained as a signalingmolecule with the capacity to promote caspase ac-
tivation [22]. The observed NO-dependent metacaspase speciﬁc
cleavage of GAPDHmight also be explained by the capacity of NO in ac-
tivating metacaspase as previously reported [7]. Further studies might
help in elucidating the relation between NO signaling and metacaspase
speciﬁc GAPDH cleavage. Nonetheless, all these results call attention to
the relevance of metabolic enzyme cleavage during H2O2-induced apo-
ptosis. Metabolic enzymes have complex roles, having proved their
multi-functional relation with different cellular processes, including
cell death [23,24]. In fact, GAPDH has been extensively implicated in
2049A. Silva et al. / Biochimica et Biophysica Acta 1813 (2011) 2044–2049several mammalian apoptotic processes [25]. Additionally, alterations
in metabolic pathways are often related to neurodegenerative diseases,
cell damaging processes and cancers [23,25]. Our ﬁndings herein de-
scribed demonstrate for the ﬁrst time a yeast metacaspase speciﬁc sub-
strate, GAPDH. The data obtained open new perspectives for the precise
identiﬁcation of the molecular cascade regulated by metacaspase acti-
vation and its relevance to yeast apoptotic cell death.
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